The Valley Desk

NCT01283516 · Interventional trial

A Dose Escalation/Expansion Study of LDK378 in Patients With Tumors Characterized by Genetic Abnormalities in Anaplastic Lymphoma Kinase

Overall registry status Completed

Phase 1

Conditions Tumors Characterized by Genetic Abnormalities of ALK

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov